JEFFREY KIENZLE: Open Payments
NPI 1073545471 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,549 in 118 payments from 16 companies in 2025. Trend: 2023 $1,165 · 2024 $2,189 · 2025 $3,549
Food & beverage: $2,655Travel & lodging: $788Education: $106
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 13 | $1,099 |
| AstraZeneca Pharmaceuticals LP | 19 | $520 |
| Insmed, Inc. | 14 | $380 |
| GlaxoSmithKline, LLC. | 20 | $324 |
| Actelion Pharmaceuticals US, Inc. | 14 | $286 |
| Merck Sharp & Dohme LLC | 7 | $219 |
| Regeneron Healthcare Solutions, Inc. | 5 | $175 |
| GENZYME CORPORATION | 6 | $163 |
| Verona Pharma, Inc. | 4 | $106 |
| Electromed, Inc. | 7 | $69 |
Products named: INSPIRE, Arikayce, DUPIXENT, AIRSUPRA, TRELEGY ELLIPTA, WINREVAIR, OPSUMIT, FASENRA.
Industry payments across FL — which companies pay providers there.
